Market Cap 2.32B
Revenue (ttm) 838.00M
Net Income (ttm) 100.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.94
Profit Margin 12.03%
Debt to Equity Ratio 0.11
Volume 106,700
Avg Vol 74,182
Day's Range N/A - N/A
Shares Out 174.32M
Stochastic %K 38%
Beta 0.81
Analysts Strong Sell
Price Target $25.38

Latest News on HCM

HUTCHMED (China) Ltd (HCM) Shares Up 2.9% on Oct 2

Oct 2, 2024, 12:04 PM EDT - 3 months ago

HUTCHMED (China) Ltd (HCM) Shares Up 2.9% on Oct 2


HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia

Aug 21, 2024, 4:30 AM EDT - 5 months ago

HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia


Hutchmed Growing Sales By 64% In H1 2024

Aug 9, 2024, 2:08 AM EDT - 5 months ago

Hutchmed Growing Sales By 64% In H1 2024


HUTCHMED (China) Limited (HCM) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 1:55 PM EDT - 6 months ago

HUTCHMED (China) Limited (HCM) Q2 2024 Earnings Call Transcript


HUTCHMED to Announce 2024 Half-Year Financial Results

Jun 26, 2024, 4:30 AM EDT - 7 months ago

HUTCHMED to Announce 2024 Half-Year Financial Results


Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024

Jun 24, 2024, 5:30 AM EDT - 7 months ago

Save the Date: HUTCHMED to Present R&D Updates on July 9, 2024


HUTCHMED Highlights Data to be Presented at AACR Congress 2024

Apr 5, 2024, 4:30 AM EDT - 10 months ago

HUTCHMED Highlights Data to be Presented at AACR Congress 2024


HUTCHMED (China) Limited (HCM) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 1:25 PM EST - 11 months ago

HUTCHMED (China) Limited (HCM) Q4 2023 Earnings Call Transcript


HUTCHMED to Announce 2023 Final Results

Feb 1, 2024, 3:30 AM EST - 1 year ago

HUTCHMED to Announce 2023 Final Results